| Date Initiated by Firm | July 21, 2003 |
| Date Posted | August 20, 2003 |
| Recall Status1 |
Terminated 3 on August 20, 2003 |
| Recall Number | Z-1141-03 |
| Recall Event ID |
26854 |
| Product Classification |
Stent, Coronary - Product Code MAF
|
| Product | BiodivYsio SV Over The Wire (OTW) Coronary Stent, 2.25 mm diameter;
Catalog #: B3225-10, Lot #: 010586G;
Catalog #: B3225-10, Lot #: 030176G;
Catalog #: B3225-15, Lot #: 010626G;
Catalog #: B3225-18, Lot #: 020246G. |
| Code Information |
Catalog #: B3225-10, Lot #: 010586G; Catalog #: B3225-10, Lot #: 030176G; Catalog #: B3225-15, Lot #: 010626G; Catalog #: B3225-18, Lot #: 020246G. |
| FEI Number |
3000718335
|
Recalling Firm/ Manufacturer |
Abbott Vascular Devices 400 Saginaw Drive Redwood City CA 94063
|
| For Additional Information Contact | Denise Singleton, JD, RAC 650-474-3193 |
Manufacturer Reason for Recall | The medical device is misbranded in that the compliance chart of the Stent diameter may allow overexpansion that may result in vessel damage. |
FDA Determined Cause 2 | Other |
| Action | On 7/21/03, the firm issued letters via Federal Express to all its direct consignees, informing them of the affected devices and providing instructions on the recall. |
| Distribution | Product received nationwide distribution to approx. 38 direct consignees. The recall was appropriately extended to the user level; i.e., the hospital/medical centers, physicians who received the recalled product.
There is no known Canadian distribution.
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|